Type 2 diabetes and cognitive impairment: linking mechanisms - Test2 - elhamkhani - TriplyDB

Type 2 diabetes and cognitive impairment: linking mechanisms

Type 2 diabetes and cognitive impairment: linking mechanisms

http://www.wikidata.org/entity/Q26822993

about

Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic rats Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease Link between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatment Reduced Gray Matter Volume in Patients with Type 2 Diabetes Mellitus.Decreased neuronal bursting and phase synchrony in the hippocampus of streptozotocin diabetic rats Neuroinflammation and neurologic deficits in diabetes linked to brain accumulation of amylin.Functional MRI signal fluctuations: a preclinical biomarker for cognitive impairment in type 2 diabetes?Folic acid attenuates cognitive dysfunction in streptozotocin-induced diabetic rats Relationships among serum C-reactive protein, receptor for advanced glycation products, metabolic dysfunction, and cognitive impairments Cerebral structural changes in diabetic kidney disease: African American-Diabetes Heart Study MIND.Increased protein aggregation in Zucker diabetic fatty rat brain: identification of key mechanistic targets and the therapeutic application of hydrogen sulfide.Obesity and Hepatic Steatosis Are Associated with Elevated Serum Amyloid Beta in Metabolically Stressed APPswe/PS1dE9 Mice Inflammation-associated declines in cerebral vasoreactivity and cognition in type 2 diabetes Racial-ethnic disparities in the association between risk factors and diabetes: The Northern Manhattan Study Dopamine pathway gene variants may modulate cognitive performance in the DHS - Mind Study Stroke Symptoms With Absence of Recognized Stroke Are Associated With Cognitive Impairment and Depressive Symptoms in Older Adults With Diabetes.Higher serum glucose levels are associated with cerebral hypometabolism in Alzheimer regions Hyperamylinemia as a risk factor for accelerated cognitive decline in diabetes Glycemic control, cognitive function, and family support among middle-aged and older Hispanics with diabetes: The Hispanic Community Health Study/Study of Latinos The negative effects of obesity and poor glycemic control on cognitive function: a proposed model for possible mechanisms.Insulin signaling controls neurotransmission via the 4eBP-dependent modification of the exocytotic machinery.Metabolic relationship between diabetes and Alzheimer's Disease affected by Cyclo(His-Pro) plus zinc treatment.Steps to Health in Cognitive Aging: Effects of Physical Activity on Spatial Attention and Executive Control in the Elderly.Low-Molecular-Weight NGF Mimetic Corrects the Cognitive Deficit and Depression-like Behavior in Experimental Diabetes.Molecular interaction between type 2 diabetes and Alzheimer's disease through cross-seeding of protein misfolding.Does supplementation with carnosine improve cardiometabolic health and cognitive function in patients with pre-diabetes and type 2 diabetes? study protocol for a randomised, double-blind, placebo-controlled trial.Association Between Chronic Conditions and Physical Function Among Veteran and Non-Veteran Women With Diabetes.Amylin: what might be its role in Alzheimer's disease and how could this affect therapy?Erythrocytes as Potential Link between Diabetes and Alzheimer's Disease Decision-making in primary onset middle-age type 2 diabetes mellitus: a BOLD-fMRI study.Profiling of cardio-metabolic risk factors and medication utilisation among Type II diabetes patients in Ghana: a prospective cohort study.Is There Inflammatory Synergy in Type II Diabetes Mellitus and Alzheimer's Disease?Complications of Diabetes.Abnormal myosin phosphatase targeting subunit 1 phosphorylation and actin polymerization contribute to impaired myogenic regulation of cerebral arterial diameter in the type 2 diabetic Goto-Kakizaki rat.First translational 'Think Tank' on cerebrovascular disease, cognitive impairment and dementia.The TOMM40 poly-T rs10524523 variant is associated with cognitive performance among non-demented elderly with type 2 diabetes.Incorporation of suboptimal health status as a potential risk assessment for type II diabetes mellitus: a case-control study in a Ghanaian population.Analysis of neuron-astrocyte metabolic cooperation in the brain of db/db mice with cognitive decline using 13C NMR spectroscopy.Cognitive deficits and Alzheimer-like neuropathological impairments during adolescence in a rat model of type 2 diabetes mellitus

P2860

Q26747585-579C9ECB-7717-4DF5-B2D0-36B0AA20D12C Q26748713-67CF3C44-8E67-4668-BA97-E63D589E82B8 Q26860246-11D13ED1-0450-41B6-8215-9B21B0EAE4F8 Q33711217-FCB7C4D5-F9ED-44E6-B445-BA3454A5D42B Q33908628-52842DAC-EB66-45E8-949F-DE18A2634430 Q34089002-A27F0BD4-D6AC-495D-8E2C-52B3CD18ECCF Q34263961-0782BE81-E945-4291-A1A8-AA049FEE5552 Q34769924-28A96FBC-B0A5-4D01-A958-2B2AB3F288E7 Q34974412-5A355DAB-4F69-4D36-A097-145D1FF866DB Q34996879-EA03BA23-A23C-483B-BB20-94CA3489E66E Q35083908-F643C82C-6A45-4208-90E6-B7459B3058EF Q35921128-53F7560B-02B7-4920-A046-F4ACC4A41031 Q35945738-04E846A0-3AC0-4EEC-A7D5-26755EEBFC1F Q36494160-B321B823-E097-4AA6-8FE0-7121D1D36519 Q36702246-97DDB907-4123-4F9C-8BEB-E01FA634ECF3 Q36772278-001B44D3-9B58-48AD-A6BD-D2F691074B9F Q36870173-0EAF2E7A-51E7-4BA9-8BA1-B836D13ED0D1 Q37019858-D8D861F0-CF75-41B7-9E5C-85CCB03CBBF6 Q37031336-46AB0FF9-EE38-4D1F-B9A6-E2E227F27E4F Q37197540-8684CA8E-4F87-4C77-BE5B-E62C590F87BE Q37235201-064668C3-D570-4B99-B26C-4A516A394F46 Q37569276-EDFCB8B6-88E8-48C6-855F-9DBB545DC823 Q37681544-F1749D20-5C8A-4CE6-A6AB-70FAF77B0ED2 Q38663285-6B070AA9-2FD4-46F5-90E8-5A32314999EE Q39043775-B20C70F0-59F7-4E39-A852-4687DDFE933B Q40060825-9B872DCE-E0CA-4CF8-965C-B2639143446E Q40107256-68F36231-9D7B-4DC3-BB86-60A5BE33DF6E Q41091464-C7CABBCA-3486-4222-AC48-0B2EDCC5F6A7 Q41547214-5BD0E88F-FF1F-43DF-8B5D-F28E6342A159 Q41580078-9B5FE433-0691-49B5-AA6A-1E0D72962838 Q41636583-BF9EE109-08CC-4A8F-B2CD-DAA4A268EDC6 Q42055616-15081430-CB7E-47DB-B4FB-F031C6659E16 Q42390608-A30FE0D3-7DB9-4C23-813C-0886871E48C4 Q42486934-8A255DE4-06CE-48EF-AEA9-E793B5DD8FF2 Q42568045-C3DF7D3E-FDC7-4F5A-947E-915AB2E1FCC0 Q47159488-379F9635-91A3-4808-AE18-95387ECCCD1A Q47568764-31A3B721-CD67-4BF0-8658-C5592576FC12 Q52144834-52EB35DA-4546-4A8A-A7FD-C8E0FFE91719 Q58702626-60AF159D-968F-472E-AD31-07DB04AF23AF

P2860

Type 2 diabetes and cognitive impairment: linking mechanisms

http://www.wikidata.org/entity/Q26822993

description

2012 nî lūn-bûn

@nan

2012 թուականին հրատարակուած գիտական յօդուած

@hyw

2012 թվականին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Type 2 diabetes and cognitive impairment: linking mechanisms

@ast

Type 2 diabetes and cognitive impairment: linking mechanisms

@en

Type 2 diabetes and cognitive impairment: linking mechanisms

@nl

type

label

Type 2 diabetes and cognitive impairment: linking mechanisms

@ast

Type 2 diabetes and cognitive impairment: linking mechanisms

@en

Type 2 diabetes and cognitive impairment: linking mechanisms

@nl

prefLabel

Type 2 diabetes and cognitive impairment: linking mechanisms

@ast

Type 2 diabetes and cognitive impairment: linking mechanisms

@en

Type 2 diabetes and cognitive impairment: linking mechanisms

@nl

P1433

Q26822993-2F04D339-5CA0-45A3-9A3A-6969843550FD

P1476

Q26822993-982E5EAB-CEEC-48E2-8421-6BEB8CD173B1

P2093

Q26822993-312907DD-5BBE-4413-B9ED-78E07CD07903

P2860

Q26822993-013E722D-F0A4-4773-BC6B-044AFF57E4EA

Q26822993-0161EA53-A9DE-4A63-B549-F3A41197FD33

Q26822993-07633A18-BD46-4C18-90A5-45C6D36C5FA2

Q26822993-086F36F8-3750-44E1-B483-B34FDE333C28

Q26822993-08B5909B-F1D1-43B5-A572-1E92EEC2ED89

Q26822993-0BAEF834-B8B2-4793-8805-176998BA4DCD

Q26822993-14B157BE-555D-4606-BBD6-91FBCDBF4A36

Q26822993-155F9C7C-D18A-40D2-8EB4-C2DC1FE073DC

Q26822993-1C58ED9A-F319-49BF-8C7B-C15A2B02B8A3

Q26822993-1D7ABD82-1B31-4EB3-B0FF-BD0B742B1C23

P304

Q26822993-38B36890-3CAB-4FA7-A657-29D8844DCBBE

P31

Q26822993-6B5B7ADB-4D8C-46EB-A4A3-8C75671AB44A

P3181

Q26822993-13EB0CFA-3403-4D38-B3CF-5D94C47C4272

P356

Q26822993-7BC24EA1-E7CB-4EFE-BBD8-56E63706F268

P407

Q26822993-9154FA7A-7FAD-4757-95F0-20505F81A516

P478

Q26822993-3BB796AD-5682-4CBD-AEBE-6265861AFE3A

P50

Q26822993-880D57B2-4B0E-4C78-98D0-30E0F7C03A0A

P577

Q26822993-494E56A1-9256-4CA4-BDC5-8ABDF5D12A58

P698

Q26822993-3EE79C7F-60A8-4255-B989-E76A5224143C

P921

Q26822993-D075639B-18CB-40F7-9EB5-13AD224A5FED

P932

Q26822993-FA1187FA-6D56-4405-9CD8-280E095418DA

P3181

P356

JAD-2012-111433

P1433

Journal of Alzheimer's Disease

P1476

Type 2 diabetes and cognitive impairment: linking mechanisms

@en

P2093

Luchsinger JA

http://www.w3.org/2001/XMLSchema#string

P2860

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

Clearance of amyloid-beta by circulating lipoprotein receptors

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study

Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo

Mild cognitive impairment: clinical characterization and outcome

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

Lifetime risk for diabetes mellitus in the United States

P304

S185-98

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4086446

http://www.w3.org/2001/XMLSchema#string

P356

10.3233/JAD-2012-111433

http://www.w3.org/2001/XMLSchema#string

P407

P478

30 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P50

José A Luchsinger

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22433668

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

3372666

http://www.w3.org/2001/XMLSchema#string